Healthcare Global Enterprises Ltd Analyst Rating
based on 11 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 11 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹496.36
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Share analysis
Healthcare Global Enterprises Ltd price forecast by 11 analysts
Upside of6.17%
High
₹560
Target
₹496.36
Low
₹407
Healthcare Global Enterprises Ltd target price ₹496.36, a slight upside of 6.17% compared to current price of ₹468.5. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Healthcare Global Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2026:34.84%
Forecast
Actual
Including amortisation and stock based compensations
Healthcare Global Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2026:143.35%
Forecast
Actual
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Performance
Day's Low
Day's High
₹464₹47552 Week's Low
52 Week's High
₹314₹519.5
| Returns % | |
| 1 Month Return | + 9.45 % |
| 3 Month Return | + 28.59 % |
| 1 Year Return | + 26.42 % |
| Market Stats | |
| Previous Close | ₹467.50 |
| Open | ₹470.05 |
| Volume | 1.23L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹6,516.33Cr |
Healthcare Global Enterprises Ltd Key Statistics
| P/E Ratio | 114.02 |
| PEG Ratio | 79.18 |
| Market Cap | ₹6,516.33 Cr |
| P/B Ratio | 3.96 |
| EPS | 2.97 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 3.22 |
Healthcare Global Enterprises Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹6,516.33 Cr | 64.69% | 0.70 | ₹41 Cr | ₹1,907 Cr | |
| BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| NA | ₹80.50 Cr | 34.74% | 0.56 | -₹2 Cr | ₹39 Cr | |
| NA | ₹39.83 Cr | 32.5% | 1.33 | ₹2 Cr | ₹10 Cr | |
| NA | ₹3,806.60 Cr | 174.5% | 0.56 | NA | NA |
Healthcare Global Enterprises Ltd Mutual Fund Holdings
About Healthcare Global Enterprises Ltd
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Share Price: ₹468.50 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹6,516.33Cr as of today
Revenue: ₹552.47Cr as on September 2024 (Q3 24)
Net Profit: ₹20.68Cr as on September 2024 (Q3 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Healthcare Global Enterprises Ltd
Healthcare Global Partners with JBG Invincible Women's Run - 14 Nov, 2024
Healthcare Global Enterprises Limited will provide free health check-ups for participants of the JBG Invincible Women's Run with Pinkathon Mumbai 2024, enhancing community health engagement.
HCG Reports Strong Q2 Growth; Buy Rating Maintained - 13 Nov, 2024
Healthcare Global Enterprises (HCG) reported a 21% YoY growth in Q2 consolidated EBITDA, reaching Rs 1.02 billion. Analysts expect further margin improvements and maintain a BUY rating with a target price of Rs 535, reflecting a 22% EBITDA CAGR over FY24-27E.
Healthcare Global Reports Strong Sales and Strategic Sale - 11 Nov, 2024
Healthcare Global Enterprises Ltd reported strong financial results for September 2024, with standalone and consolidated net sales increasing significantly. The company also plans to sell its Triesta diagnostic business for Rs 135 crore to focus on growth opportunities.
Healthcare Global Enterprises Reports Growth and Acquisition - 09 Nov, 2024
Healthcare Global Enterprises announced strong Q2 FY25 results with revenue of ₹552.47 crore and profit of ₹20.68 crore. Additionally, the company signed a BTA to acquire the oncology business from HCG NCHRI Oncology LLP for up to ₹25 crore.
KKR in Talks to Acquire HealthCare Global Stake - 28 Oct, 2024
KKR is in exclusive negotiations to acquire a controlling stake in HealthCare Global Enterprises from CVC Capital, valued at around Rs 3,613.97 crore. This acquisition could trigger a mandatory open offer for public shareholders. The hospital chain reported significant revenue and profit growth in the last quarter.
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.95% to 4.29% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 12.08 Cr → 17.99 Cr (in ₹), with an average increase of 32.9% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 475.94 Cr → 564.67 Cr (in ₹), with an average increase of 5.5% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 8.73% to 8.94% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, HCG stock has moved up by 9.5%
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 76.6% return, outperforming this stock by 50.2%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.3% return, outperforming this stock by 104.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 13.90% to 12.83% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.25% to 71.23% in Sep 2024 quarter
Healthcare Global Enterprises Ltd Financials
Index Inclusions
Healthcare Global Enterprises Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.23% | ||
| Foreign Institutions | 4.29% | 8.63 | |
| Mutual Funds | 8.94% | 2.44 | |
| Retail Investors | 12.83% | ||
| Others | 2.7% | 24.92 |
Healthcare Global Enterprises Ltd Key Indicators
Healthcare Global Enterprises Ltd Valuation
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (96.41x)
November 19, 2024
Today (114.02x)
November 19, 2024
Highest (201.31x)
July 2, 2018
Healthcare Global Enterprises Ltd Earnings and Dividends
Healthcare Global Enterprises Ltd Earnings Results
Healthcare Global Enterprises Ltd’s net profit jumped 32.57% since last year same period to ₹17.99Cr in the Q2 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated 48.92% jump in its net profits since last 3-months.
Read More about Earnings Results
Healthcare Global Enterprises Ltd Technicals Summary
Bearish
Neutral
Bullish
Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Healthcare Global Enterprises Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Healthcare Global Enterprises Ltd shares.
Healthcare Global Enterprises Ltd (HCG) share price today is ₹468.5
Healthcare Global Enterprises Ltd is listed on NSE
Healthcare Global Enterprises Ltd is listed on BSE
- Today’s highest price of Healthcare Global Enterprises Ltd is ₹475.
- Today’s lowest price of Healthcare Global Enterprises Ltd is ₹464.
PE Ratio of Healthcare Global Enterprises Ltd is 114.02
PE ratio = Healthcare Global Enterprises Ltd Market price per share / Healthcare Global Enterprises Ltd Earnings per share
Today’s traded volume of Healthcare Global Enterprises Ltd(HCG) is 1.23L.
Today’s market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹6516.33Cr.
| Healthcare Global Enterprises Ltd(HCG | Price |
|---|---|
52 Week High | ₹519.5 |
52 Week Low | ₹314 |
Healthcare Global Enterprises Ltd(HCG) share price is ₹468.5. It is down -9.82% from its 52 Week High price of ₹519.5
Healthcare Global Enterprises Ltd(HCG) share price is ₹468.5. It is up 49.20% from its 52 Week Low price of ₹314
| Healthcare Global Enterprises Ltd(HCG | Returns |
|---|---|
1 Day Returns | 1% |
1 Month Returns | 9.45% |
3 Month Returns | 28.59% |
1 Year Returns | 26.42% |